Crestline Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,801
| Closed | -$453K | – | 273 |
|
|
2024
Q4 | $453K | Buy |
5,801
+747
| +15% | +$58.3K | 0.02% | 554 |
|
|
2024
Q3 | $406K | Buy |
+5,054
| New | +$406K | 0.02% | 402 |
|
|
2022
Q1 | – | Sell |
-4,137
| Closed | -$219K | – | 281 |
|
|
2021
Q4 | $219K | Sell |
4,137
-69,951
| -94% | -$3.7M | 0.02% | 185 |
|
|
2021
Q3 | $5.23M | Buy |
+74,088
| New | +$5.23M | 0.49% | 39 |
|